User menu

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.

Bibliographic reference Kappos, Ludwig ; Freedman, Mark S ; Polman, Chris H ; Edan, Gilles ; Hartung, Hans-Peter ; et. al. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.. In: The Lancet Neurology, Vol. 8, no.11, p. 987-97 (2009)
Permanent URL http://hdl.handle.net/2078.1/125000